About Dolphin Pharmaceutical Limited
Data last updated:
Dolphin Pharmaceutical Limited is a public limited company based in Surat, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2011PLC064980. Its GSTIN is 24AADCD8575D1ZO (Gujarat).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh. It is led by directors including Dilipbhai Devchandbhai Zalawadiya and Hareshkumar Babubhai Sorathiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 155/156/157 New Sardar Market (A.P.M.C) Commercial Complex Puna Kumbharia Road, Surat, Gujarat, India – 395010.
The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹25 Lakh; the latest was in March 2015.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dolphinpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address155/156/157 New Sardar Market (A.P.M.C) Commercial Complex Puna Kumbharia Road, Surat, Gujarat, India – 395010
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dolphin Pharmaceutical Limited
The main business activity of Dolphin Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dolphin Pharmaceutical Limited FY 2025 filings available
Financial Statement Summary of Dolphin Pharmaceutical Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dolphin Pharmaceutical Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dolphin Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical Limited is audited by J V KANANI & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J V KANANI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilipbhai Devchandbhai Zalawadiya | Director | 16 Apr 2011 | 15 Years 5 Months | Current |
| Hareshkumar Babubhai Sorathiya Also directs: Janvi Impex Private Limited | Director | 16 Apr 2011 | 15 Years 5 Months | Current |
| Jaysukhbhai Devchandbhai Zalawadiya Also directs: Janvi Impex Private Limited | Director | 16 Apr 2011 | 15 Years 5 Months | Current |
Ownership and Shareholding of Dolphin Pharmaceutical Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹25 Lakh; the latest was in March 2015.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2013 | Funding round | ₹25 Lakh | Investors: 4 individuals |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Dolphin Pharmaceutical Limited
Employment history and EPFO contributions of people linked to Dolphin Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical Limited has 3 board changes on record since 2011: 3 appointments. The latest: Dilipbhai Devchandbhai Zalawadiya was appointed as Director on 16 Apr 2011.
Credit Ratings, Litigation & Regulatory Alerts for Dolphin Pharmaceutical Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dolphin Pharmaceutical Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dolphin Pharmaceutical Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCD8575D1ZO | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dolphin Pharmaceutical Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dolphin Pharmaceutical Limited
Dolphin Pharmaceutical is an active public limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2011 (15+ years old) and is registered under CIN U24230GJ2011PLC064980.
Dolphin Pharmaceutical has 3 current directors:
- Dilipbhai Devchandbhai Zalawadiya - Director
- Hareshkumar Babubhai Sorathiya - Director
- Jaysukhbhai Devchandbhai Zalawadiya - Director
The GSTIN of Dolphin Pharmaceutical is 24AADCD8575D1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Dolphin Pharmaceutical is U24230GJ2011PLC064980. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dolphin Pharmaceutical was incorporated on 16 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dolphin Pharmaceutical has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹25 Lakh; the latest was in March 2015.
Dilipbhai Devchandbhai Zalawadiya was appointed as Director on 16 Apr 2011. Hareshkumar Babubhai Sorathiya was appointed as Director on 16 Apr 2011. Jaysukhbhai Devchandbhai Zalawadiya was appointed as Director on 16 Apr 2011.
Dolphin Pharmaceutical can be reached through the website dolphinpharma.com. Its registered office is in Surat, Gujarat, India.
The registered office of Dolphin Pharmaceutical is at 155156157 New Sardar Market A.P.M.C Commercial Complex Puna Kumbharia Road, Surat, Gujarat, India – 395010.
Dolphin Pharmaceutical has an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh.